Enter assignee name

% Expired Patents = 23.1

EPO Patents = 5

Trademarks = 3

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Tong Wang (13 out of 23 patents)

Stephen Gately (13 out of 24 patents)

Paul Gonzales (3 out of 3 patents)

13 patents: Sort by Forward Citations

1. 12076401 - Benzamide and active compound compositions and methods of use (2024-09-03),

2. 11780816 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (2023-10-10),

3. 11555039 - Amide compounds as kinase inhibitors, compositions and methods of treatment (2023-01-17),

4. 11420947 - (S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereof (2022-08-23),

5. 11236052 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (2022-02-01),

6. 10881733 - Benzamide and active compound compositions and methods of use (2021-01-05),

7. 10807966 - Heterocyclic compounds as kinase inhibitors (2020-10-20),

8. 10780080 - Benzamide and active compound compositions and methods of use (2020-09-22),

9. 10633393 - Heterocyclic compounds as kinase inhibitors (2020-04-28),

10. 10590088 - 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof (2020-03-17),

11. 10584119 - Pyrazole compounds and methods of use thereof (2020-03-10),

12. 10392402 - Heterocyclic compounds as kinase inhibitors (2019-08-27),

13. 10131654 - Pyrazole compounds and methods of use thereof (2018-11-20),

Translational Drug Development, LLC is a leading contract research organization (CRO) that offers integrated services to support the development of cancer drugs. They specialize in providing strategic and operational solutions throughout the drug development process, from preclinical research to clinical trials. With expertise in translational medicine, pharmacokinetics, and bioanalytical sciences, they assist pharmaceutical and biotechnology companies in bringing innovative cancer therapies to market faster.

Profile summary based on public USPTO records.